New Zealand - English - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - foscarnet sodium hexahydrate 24 mg/ml - solution for infusion - 24 mg/ml - active: foscarnet sodium hexahydrate 24 mg/ml - treatment of cytomegalovirus (cmv) retinitis in patients with acquired immunodeficiency syndrome (aids). treatment of acyclovir resistant herpes simplex virus (hsv) infections in immunocompromised patients. the safety and efficacy of foscavir for the treatment of other hsv infections (e.g. retinitis, encephalitis); congenital or neonatal disease; or hsv in immunocompetent individuals has not been established.

United States - English - NLM (National Library of Medicine)

bioactive nutritional, inc. - phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r) - phenylalanine 6 [hp_x] in 1 ml - for temporary relief of blurred vision, mentally sluggish, mood swings, gas, headaches, inability to concentrate, chest congestion with constriction and generalized pain. for temporary relief of blurred vision, mentally sluggish, mood swings, gas, headaches, inability to concentrate, chest congestion with constriction and generalized pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - nitisinone, quantity: 4 mg - oral liquid, suspension - excipient ingredients: hypromellose; glycerol; polysorbate 80; sodium benzoate; citric acid monohydrate; sodium citrate; purified water; flavour - orfadin (nitisinone) is indicated for the treatment of patients with hereditary tyrosinaemia type 1 in combination with dietary restriction of tyrosine and phenylalanine.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

fresenius kabi austria gmbh - l-isoleucine, l-leucine, l-lysine (lysine acetate), l-methionine, l-phenylalanine, l-threonine, l-triyptophan, l-valine, l-arginine, l-histidine, l-alanine, glycine, l-proline, l-serine, l-tyrosine, taurine - solution for infusion - 5mg/ml+7,4mg/ml+6,6mg/ml+4,3mg/ml+5,1mg/ml+4,4mg/ml+2mg/ml+6,2mg/ml+12mg/ml+3mg/ml+14mg/ml+11mg/ml+11,2mg/ml+6,5mg/ml+0,4mg/ml+1

New Zealand - English - Medsafe (Medicines Safety Authority)

abbott laboratories (nz) ltd - alanine 6.4 mg/ml; arginine 4.9 mg/ml; glycine 6.4 mg/ml; histidine 1.5 mg/ml; isoleucine 3.6 mg/ml; leucine 4.7 mg/ml; lysine 3.6 mg/ml; methionine 2 mg/ml; phenylalanine 2.2 mg/ml; proline 4.3 mg/ml; serine 2.1 mg/ml; threonine 2.6 mg/ml; tryptophan 0.8 mg/ml; tyrosine 0.44 mg/ml; valine 4 mg/ml - solution for infusion - 5 % - active: alanine 6.4 mg/ml arginine 4.9 mg/ml glycine 6.4 mg/ml histidine 1.5 mg/ml isoleucine 3.6 mg/ml leucine 4.7 mg/ml lysine 3.6 mg/ml methionine 2 mg/ml phenylalanine 2.2 mg/ml proline 4.3 mg/ml serine 2.1 mg/ml threonine 2.6 mg/ml tryptophan 0.8 mg/ml tyrosine 0.44 mg/ml valine 4 mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

intermed medical ltd - alanine 8.44 mg/ml; arginine 8.65 mg/ml; aspartic acid 5.95 mg/ml; glutamic acid 6.27 mg/ml; glycine 4.25 mg/ml; histidine 2.55 mg/ml; isoleucine 5.61 mg/ml; leucine 8.5 mg/ml; lysine 8.93 mg/ml; methionine 1.46 mg/ml; phenylalanine 2.53 mg/ml; proline 6.14 mg/ml; serine 4.5 mg/ml; threonine 3.4 mg/ml; tryptophan 1.7 mg/ml; tyrosine 2.3 mg/ml; valine 4.25 mg/ml - solution for infusion - 8.5 % - active: alanine 8.44 mg/ml arginine 8.65 mg/ml aspartic acid 5.95 mg/ml glutamic acid 6.27 mg/ml glycine 4.25 mg/ml histidine 2.55 mg/ml isoleucine 5.61 mg/ml leucine 8.5 mg/ml lysine 8.93 mg/ml methionine 1.46 mg/ml phenylalanine 2.53 mg/ml proline 6.14 mg/ml serine 4.5 mg/ml threonine 3.4 mg/ml tryptophan 1.7 mg/ml tyrosine 2.3 mg/ml valine 4.25 mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

intermed medical ltd - alanine 8.44 mg/ml; arginine 8.65 mg/ml; aspartic acid 5.95 mg/ml; chlorine 0.086 meq/ml; glutamic acid 6.27 mg/ml; glycine 4.25 mg/ml; histidine 2.55 mg/ml; isoleucine 5.61 mg/ml; leucine 8.5 mg/ml; lysine 8.93 mg/ml (from lysine acetate - 0.061meq/ml acetate also present); magnesium 0.01 meq/ml; methionine 1.46 mg/ml; phenylalanine 2.53 mg/ml; phosphorus 0.03 meq/ml; potassium 0.066 meq/ml; proline 6.14 mg/ml; serine 4.5 mg/ml; sodium 0.08 meq/ml; threonine 3.4 mg/ml; tryptophan 1.7 mg/ml; tyrosine 2.3 mg/ml; valine 4.25 mg/ml - solution for infusion - 8.5 % - active: alanine 8.44 mg/ml arginine 8.65 mg/ml aspartic acid 5.95 mg/ml chlorine 0.086 meq/ml glutamic acid 6.27 mg/ml glycine 4.25 mg/ml histidine 2.55 mg/ml isoleucine 5.61 mg/ml leucine 8.5 mg/ml lysine 8.93 mg/ml (from lysine acetate - 0.061meq/ml acetate also present) magnesium 0.01 meq/ml methionine 1.46 mg/ml phenylalanine 2.53 mg/ml phosphorus 0.03 meq/ml potassium 0.066 meq/ml proline 6.14 mg/ml serine 4.5 mg/ml sodium 0.08 meq/ml threonine 3.4 mg/ml tryptophan 1.7 mg/ml tyrosine 2.3 mg/ml valine 4.25 mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

biomed limited - alanine 5.4 mg/ml; arginine 12 mg/ml; aspartic acid 3.2 mg/ml; cysteine 0.16 mg/ml; glutamic acid 5 mg/ml; glycine 3.6 mg/ml; histidine 4.8 mg/ml; isoleucine 8.2 mg/ml; leucine 14 mg/ml; lysine 8.2 mg/ml; methionine 3.4 mg/ml; phenylalanine 4.8 mg/ml; proline 6.8 mg/ml; serine 3.8 mg/ml; taurine 0.25 mg/ml; threonine 4.2 mg/ml; tryptophan 2 mg/ml; tyrosine 2.4 mg/ml; valine 7.8 mg/ml - solution for infusion - 10 % - active: alanine 5.4 mg/ml arginine 12 mg/ml aspartic acid 3.2 mg/ml cysteine 0.16 mg/ml glutamic acid 5 mg/ml glycine 3.6 mg/ml histidine 4.8 mg/ml isoleucine 8.2 mg/ml leucine 14 mg/ml lysine 8.2 mg/ml methionine 3.4 mg/ml phenylalanine 4.8 mg/ml proline 6.8 mg/ml serine 3.8 mg/ml taurine 0.25 mg/ml threonine 4.2 mg/ml tryptophan 2 mg/ml tyrosine 2.4 mg/ml valine 7.8 mg/ml excipient: glacial acetic acid sodium metabisulfite water for injection

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - metronidazole benzoate, quantity: 64 mg/ml - oral liquid, suspension - excipient ingredients: ethanol; monobasic sodium phosphate; aluminium magnesium silicate; methyl hydroxybenzoate; sucrose; propyl hydroxybenzoate; orange oil terpeneless; flavour - anaerobic infections treatment of infections in which anaerobic bacteria have been identified or are suspected as pathogens, particularly bacteroides fragilis and other species of bacteroides, and other species such as fusobacteria, eubacteria, clostridia and anaerobic streptococci. flagyl has been used successfully in septicaemia; bacteraemia; brain abscess; necrotising pneumonia; osteomyelitis; puerperal sepsis; pelvic abscess; pelvic cellulitis; postoperative wound infections. notes. 1. because of the slow absorption and delayed peak plasma level, flagyl suspension is not recommended for use in the acute situation. 2. metronidazole is inactive against aerobic and facultative anaerobic bacteria. other indications oral treatment of urogenital trichomoniasis in the female (trichomonal vaginitis) and in the male, and for the treatment of bacterial vaginosis. the male consort of females suffering from urogenital trichomoniasis should be treated concurrently; all forms of amoebiasis( intestinal and extraintestin

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r) - phenylalanine 6 [hp_x] in 1 ml - for temporary relief of mental sluggishness, mood swings, gas, headaches, aspartame sensitivity, food sensitivities, and poor appetite.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of mental sluggishness, mood swings, gas, headaches, aspartame sensitivity, food sensitivities, and poor appetite.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.